[HTML][HTML] Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19

Q Tan, L He, X Meng, W Wang, H Pan, W Yin… - Journal of …, 2021 - Springer
Background The worldwide pandemic of COVID-19 remains a serious public health menace
as the lack of efficacious treatments. Cytokine storm syndrome (CSS) characterized with …

COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes

MAI Al-Hatamleh, MH Ma'mon, W Alshaer… - European journal of …, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which emerged in
December 2019 and caused the coronavirus disease 2019 (COVID-19) pandemic, took the …

[HTML][HTML] Polymeric nanoparticles as therapeutic agents against coronavirus disease

LE Charelli, GC de Mattos… - Journal of Nanoparticle …, 2022 - Springer
Nanotechnology has the potential to improve the combat against life-threatening conditions.
Considering the COVID-19 scenario, and future outbreaks, nanotechnology can play a …

Macrophage-targeted nanomedicine for chronic diseases immunotherapy

Y Song, Y Huang, F Zhou, J Ding, W Zhou - Chinese Chemical Letters, 2022 - Elsevier
Macrophage is the key innate immune effector in first-line defense against the pathogens,
and can be polarized into different phenotypes to regulate a variety of immunological …

[HTML][HTML] An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19

S Yasamineh, HG Kalajahi, P Yasamineh… - Journal of …, 2022 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has
become a pandemic worldwide with mortality of millions. Nanotechnology can be used to …

[PDF][PDF] Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice

H Liu, L Wu, B Liu, K Xu, W Lei, J Deng, X Rong… - Cell Reports …, 2023 - cell.com
With the widespread vaccinations against coronavirus disease 2019 (COVID-19), we are
witnessing gradually waning neutralizing antibodies and increasing cases of breakthrough …

[HTML][HTML] Biomimetic nanoparticles potentiate the anti-inflammatory properties of dexamethasone and reduce the cytokine storm syndrome: an additional weapon …

R Molinaro, A Pasto, F Taraballi, F Giordano, JA Azzi… - Nanomaterials, 2020 - mdpi.com
Recent studies on coronavirus infectious disease 2019 (COVID-19) pathophysiology
indicated the cytokine release syndrome induced by the virus as the main cause of mortality …

Subunit nanovaccine with potent cellular and mucosal immunity for COVID-19

L Liu, Z Liu, H Chen, H Liu, Q Gao, F Cong… - ACS applied bio …, 2020 - ACS Publications
To combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
we formulated the S1 subunit of the virus with two adjuvants, amphiphilic adjuvant …

COVID-19 inflammation and implications in drug delivery

M Zoulikha, F Huang, Z Wu, W He - Journal of Controlled Release, 2022 - Elsevier
Growing evidence indicates that hyperinflammatory syndrome and cytokine storm observed
in COVID-19 severe cases are narrowly associated with the disease's poor prognosis …

[HTML][HTML] PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses

HH Park, H Kim, HS Lee, EU Seo, JE Kim, JH Lee… - Biomaterials, 2021 - Elsevier
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on a
global scale urges prompt and effective countermeasures. Recently, a study has reported …